Fluconazole Pharmacokinetics in a Morbidly Obese, Critically Ill Patient Receiving Continuous Venovenous Hemofiltration

The Evolving Role of Antifungal Susceptibility Testing

(2013) Gregory A. Eschenauer et al.   PHARMACOTHERAPY

Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review

(2011) Mahipal Sinnollareddy et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Estimating the Glomerular Filtration Rate in Obese Adult Patients for Drug Dosing

(2010) Manjunath P. Pai   ADVANCES IN CHRONIC KIDNEY DISEASE

Effect of Obesity on the Pharmacokinetics of Drugs in Humans

(2010) Michael J. Hanley et al.   CLINICAL PHARMACOKINETICS

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Principles of antibacterial dosing in continuous renal replacement therapy

(2009) Gordon Choi et al.   CRITICAL CARE MEDICINE

Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia

(2008) J. W. Baddley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Therapeutic drug monitoring for triazoles

(2008) William W Hope et al.   CURRENT OPINION IN INFECTIOUS DISEASES